Beranda › Mieloma Multipel › California › Baldwin Park
Uji klinis Mieloma Multipel di Baldwin Park, CA
23 studi untuk Mieloma Multipel mencari peserta di lokasi sekitar Baldwin Park (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
Menerima pesertaFase 1
- City of Hope National Medical Center /ID# 280273, Duarte · 4 mi jauhnya
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
Menerima pesertaFase 1
- City of Hope, Duarte · 4 mi jauhnya
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
Menerima pesertaFase 1/2
- City of Hope National Medical Center, Duarte · 4 mi jauhnya
A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)
Menerima pesertaFase 1
- Research Site, Duarte · 4 mi jauhnya
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
Menerima pesertaFase 3
- City of Hope Duarte, Duarte · 4 mi jauhnya
Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study
Menerima pesertaFase 2
- City of Hope Medical Center, Duarte · 4 mi jauhnya
A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma
Menerima pesertaFase 1/2
- City of Hope - Duarte, Duarte · 4 mi jauhnya
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Menerima pesertaFase 3
- City of Hope Duarte, Duarte · 4 mi jauhnya
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
Menerima pesertaFase 4
- City of Hope, Duarte · 4 mi jauhnya
Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma
Menerima pesertaFase 3
- City of Hope National Medical Center, Duarte · 4 mi jauhnya
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
Menerima pesertaFase 1
- City of Hope, Duarte · 4 mi jauhnya
A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma
Menerima pesertaFase 1/2
- Research Site, Duarte · 4 mi jauhnya
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
Menerima pesertaFase 1/2
- Research Site, Duarte · 4 mi jauhnya
A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)
Menerima pesertaFase 1/2
- City of Hope, Duarte · 4 mi jauhnya
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
Menerima pesertaFase 1/2
- City of Hope National Medical Center /ID# 273132, Duarte · 4 mi jauhnya
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
Menerima pesertaFase 1
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi jauhnya
Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma
Menerima peserta
- City of Hope, Duarte · 4 mi jauhnya
Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
Menerima pesertaFase 2
- City of Hope Medical Center, Duarte · 4 mi jauhnya
Mezigdomide (CC-92480) Post Idecabtagene Vicleucel in Treating Patients With Relapsed Multiple Myeloma
Menerima pesertaFase 1
- City of Hope Medical Center, Duarte · 4 mi jauhnya
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
Menerima pesertaFase 1
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi jauhnya
A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- City of Hope Medical Center, Duarte · 4 mi jauhnya
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- City of Hope, Duarte · 4 mi jauhnya
Radioimmunotherapy (111Indium/225Actinium-DOTA-daratumumab) for the Treatment of Relapsed/Refractory Multiple Myeloma
Menerima pesertaFase 1
- City of Hope Medical Center, Duarte · 4 mi jauhnya
Uji klinis Mieloma Multipel di kota lain
- New York City, NY60 studi
- Boston, MA42 studi
- Atlanta, GA41 studi
- Houston, TX38 studi
- Durham, NC37 studi
- Nashville, TN32 studi
- Denver, CO27 studi
- Rochester, MN24 studi
- St. Louis, MO24 studi
- Columbus, OH24 studi
- Chicago, IL22 studi
- Seattle, WA22 studi
Studi lain di Baldwin Park
- Kanker Payudara45 studi
- Leukemia Mieloid Akut40 studi
- Kanker Kolorektal38 studi
- Kanker Paru Non-Sel Kecil36 studi
- Kanker (semua jenis)33 studi
- Kanker Prostat30 studi
- Kanker Metastatik30 studi
- Sindrom Mielodisplastik26 studi
- Kanker Ovarium25 studi
- Kanker Paru24 studi
- Kanker Lambung22 studi
- Leukemia Limfoblastik Akut21 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.